You are here: Industry Insights > FDA

News List

FDA approves first treatment for rare form of skin cancer worldpharmanews
March 27, 2017
The U.S. Food and Drug Administration has granted accelerated approval to Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC), including those who have not received prior ch
US FDA grants Fast Track designation for Shire’s SHP655 pharmaceutical-technology
March 24, 2017
The US Food and Drug Administration (FDA) has granted Fast Track designation for Shire’s recombinant ADAMTS13 (SHP655 or previously known as BAX930) to treat acute episodes of hereditary thrombotic thrombocytopenic purpura (hTTP).
Clobetasol propionate is used for treating various skin disorders including eczema and psoriasis. biospectrumasia
March 24, 2017
The United States Food and Drug Administration (USFDA) has given its nod for Clobetasol Propionate Ointment, used for the treatment of various skin conditions.
Shire Receives FDA Fast Track Designation for Recombinant ADAMTS13 for Treatment of Hereditary Throm americanpharmaceuticalreview
March 23, 2017
Shire announced that the United States Food and Drug Administration (FDA) has granted Fast Track designation for recombinant ADAMTS13 (SHP655 - historically known as BAX930) for treatment of acute episodes...
FDA Approves Xadago® for Parkinson’s Disease Patients americanpharmaceuticalreview
March 23, 2017
Newron Pharmaceuticals S.p.A. announced that the Food and Drug Administration (FDA) has approved the use of Xadago® (safinamide) for the treatment of Parkinson’s disease as add-on therapy to levodopa/carbidopa.
FDA permits Akashi Therapeutics to resume clinical trials of experimental DMD drug HT-100 firstwordpharma
March 23, 2017
Akashi Therapeutics on Wednesday announced that it received approval from the FDA to restart clinical studies of the experimental Duchenne muscular dystrophy (DMD) treatment HT-100.
FDA OK’s first novel treatment for Parkinson’s in ten years pharmatimes
March 23, 2017
The US Food and Drug Administration has approved the first novel treatment option in more than a decade for patients...
US FDA approves Xadago to treat patients with Parkinson’s disease pharmaceutical-technology
March 23, 2017
The US Food and Drug Administration (FDA) has approved Newron Pharmaceuticals’ Xadago (safinamide) tablets to ...
Mylan receives tentative approval for "TLE400" under PEPFAR cphi-online
March 23, 2017
TLE400 is a fixed-combination containing Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets, 400 mg/300 mg/300 mg.
FDA approves drug to treat Parkinson’s disease FDA
March 23, 2017
The U.S. Food and Drug Administration today approved Xadago (safinamide) tablets as an add-on treatment for patients with Parkinson’s disease who are currently taking levodopa/carbidopa and experiencing “off” episodes.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 366 367 Next page